BioRestorative Therapies, Inc.
BRTX
$0.19
-$0.01-3.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.95M | 4.49M | 7.38M | 9.11M | 10.73M |
| Total Receivables | 15.50K | 13.40K | 15.00K | 25.00K | 188.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 327.40K | 196.70K | 184.60K | 217.40K | 213.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.50K | 7.50K | 17.30K | -- | 10.30K |
| Total Current Assets | 3.14M | 4.71M | 7.60M | 9.36M | 11.14M |
|
|
|||||
| Total Current Assets | 3.14M | 4.71M | 7.60M | 9.36M | 11.14M |
| Net Property, Plant & Equipment | 358.80K | 309.50K | 339.70K | 370.00K | 362.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 534.20K | 556.60K | 579.10K | 601.50K | 623.90K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 49.80K | 69.10K | -- | -- | 148.70K |
| Total Assets | 4.08M | 5.64M | 8.52M | 10.33M | 12.28M |
|
|
|||||
| Total Accounts Payable | 1.34M | 859.90K | 609.90K | 599.50K | 483.10K |
| Total Accrued Expenses | 1.78M | 607.50K | 480.90K | 277.60K | 719.00K |
| Short-term Debt | 42.30K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.94M | 1.97M | 2.58M | 3.31M | 2.55M |
| Total Other Current Liabilities | 2.94M | 1.97M | 2.58M | 3.31M | 2.55M |
| Total Current Liabilities | 3.72M | 3.44M | 3.67M | 4.18M | 3.75M |
|
|
|||||
| Total Current Liabilities | 3.72M | 3.44M | 3.67M | 4.18M | 3.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 42.30K | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.72M | 3.44M | 3.67M | 4.18M | 3.75M |
|
|
|||||
| Common Stock & APIC | 170.26M | 168.91M | 168.51M | 167.15M | 164.20M |
| Retained Earnings | -169.92M | -166.71M | -163.67M | -161.02M | -155.68M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 342.80K | 2.19M | 4.83M | 6.13M | 8.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
|
|
|||||
| Total Common Equity | 342.80K | 2.19M | 4.83M | 6.13M | 8.52M |
| Total Preferred Equity | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 356.70K | 2.21M | 4.85M | 6.14M | 8.53M |
|
|
|||||